Exelixis
EXEL
#1760
Rank
NZ$16.90 B
Marketcap
$59.19
Share price
0.36%
Change (1 day)
65.39%
Change (1 year)
Exelixis, Inc. is an American genomics-based drug discovery company and the producer of Cometriq, a treatment for medullary thyroid cancer.

Stock price history for Exelixis (EXEL)

Highest end of day price: $86.58 NZD on 2000-07-26

Lowest end of day price: $2.27 NZD on 2014-12-24

Stock price history of Exelixis from 2000 to 2025

Stock price for similar companies or competitors

Company Stock price Change 1d% Country
$63.95-3.50%๐Ÿ‡ฌ๐Ÿ‡ง UK
$92.94-1.18%๐Ÿ‡ซ๐Ÿ‡ท France
$154.78-1.81%๐Ÿ‡บ๐Ÿ‡ธ USA
$100.94-3.84%๐Ÿ‡บ๐Ÿ‡ธ USA
$523.47-3.26%๐Ÿ‡บ๐Ÿ‡ธ USA
$269.86-0.76%๐Ÿ‡บ๐Ÿ‡ธ USA
$45.41-2.31%๐Ÿ‡บ๐Ÿ‡ธ USA
$5.86-4.98%๐Ÿ‡บ๐Ÿ‡ธ USA
$26.37 0.00%๐Ÿ‡บ๐Ÿ‡ธ USA